PTC Therapeutics, Inc. (PTCT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for PTC Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 8.85x | -9.55x | -3.29x | -4.90x | -5.36x | -9.20x |
| P/B Ratio | -29.43x | -3.16x | -2.52x | -7.89x | 1951.79x | 8.36x |
| P/S Ratio | 3.49x | 4.30x | 2.20x | 3.92x | 5.21x | 10.58x |
| Profitability | ||||||
| Gross Margin | 95.9% | 92.9% | 93.0% | 93.6% | 94.0% | 95.0% |
| Operating Margin | 49.5% | -37.5% | -46.9% | -64.0% | -69.5% | -113.4% |
| Net Margin | 39.4% | -45.0% | -66.8% | -80.0% | -97.3% | -115.1% |
| EBITDA Margin | 51.3% | -14.9% | -35.2% | -52.6% | -68.4% | -79.6% |
| Liquidity | ||||||
| Current Ratio | 2.35x | 2.35x | 2.02x | 1.71x | 1.87x | 4.44x |
| Quick Ratio | 2.27x | 2.31x | 1.97x | 1.65x | 1.84x | 4.37x |
| Leverage | ||||||
| Debt/Equity | -2.40x | -2.25x | -2.72x | -4.21x | 882.73x | 0.87x |
YoY = year-over-year change. Source: FMP..